Tranexamic acid in cardiac surgery: Are low doses enough?;Ácido tranexámico en cirugía cardíaca: ¿las dosis bajas son suficientes?

Revista Espanola de Anestesiologia y Reanimacion

Volumn 68, Issue 10, 2021, Pages 576-583

  Pena Borras J J ^a   Pajares Moncho, A ^b   Puig, J ^a,c   Mateo Rodriguez E ^a   Lopez Forte C ^b   Pena Perez L ^d   Moreno Pachon J ^a   Gabaldon Conejos T ^a   Perez Artacho J ^b   Ferrer Gomez C ^a   Ferez Marti A ^a   Lopez Cantero M ^b   de Andres Ibanez J ^a,c  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bleeding; Cardiac surgery; Convulsions; Fibrinolysis; Tranexamic acid; Transfusion

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

HEART SURGERY; HUMAN; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY;

ANTIFIBRINOLYTIC AGENTS; CARDIAC SURGICAL PROCEDURES; HUMANS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 85115022462     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2021.02.008     Document Type: Article

References (30)

1. Williams, B., McNeil, J., Crabbe, A., Tanaka, K.A., Practical use of thromboelastometry in the management of perioperative coagulopathy and bleeding. Transfus Med Rev. 31 (2017), 11–25, 10.1016/j.tmrv.2016.08.005.
2. Raphael, J., Mazer, C.D., Subramani, S., et al. Society of Cardiovascular Anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients [published correction appears in J Cardiothorac Vasc Anesth. 2020;34:840-841]. J Cardiothorac Vasc Anesth 33 (2019), 2887–2899, 10.1053/j.jvca.2019.04.003.
3. Ranucci, M., Hemostatic and thrombotic issues in cardiac surgery. Semin Thromb Hemost. 41 (2015), 84–90, 10.1055/s-0034-1398383.
4. Maeda, T., Ishihara, T., Miyata, S., et al. Evaluating the effect on mortality of a no-tranexamic acid (TXA) policy for cardiovascular surgery. J Cardiothorac Vasc Anesth. 32 (2018), 1627–1634, 10.1053/j.jvca.2017.10.018.
5. Taam, J., Yang, Q.J., Pang, K.S., et al. Current evidence and future directions of tranexamic acid use efficacy, and dosing for major surgical procedures. J Cardiothorac Vasc Anesth. 34 (2020), 782–790, 10.1053/j.jvca.2019.06.042.
6. Hessel, E.A. 2nd., What's new in cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 33 (2019), 2296–2326, 10.1053/j.jvca.2019.01.039.
7. Gerstein, N.S., Brierley, J.K., Windsor, J., et al. Antifibrinolytic agents in cardiac and noncardiac surgery: A comprehensive overview and update. J Cardiothorac Vasc Anesth. 31 (2017), 2183–2205, 10.1053/j.jvca.2017.02.029.
8. Picetti, R., Shakur-Still, H., Medcalf, R.L., Standing, J.F., Roberts, I., What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies. Blood Coagul Fibrinolysis. 30 (2019), 1–10, 10.1097/MBC.0000000000000789.
9. Lecker, I., Wang, D.S., Whissell, P.D., Avramescu, S., Mazer, C.D., Orser, B.A., Tranexamic acid-associated seizures: Causes and treatment. Ann Neurol. 79 (2016), 18–26, 10.1002/ana.24558.
10. Pagano, D., Milojevic, M., Meesters, M.I., et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg. 53 (2018), 79–111, 10.1093/ejcts/ezx325.
11. Dowd, N.P., Karski, J.M., Cheng, D.C., et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology. 97 (2002), 390–399, 10.1097/00000542-200208000-00016.
12. Horrow, J.C., van Riper, D.F., Strong, M.D., Grunewald, K.E., Parmet, J.L., The dose-response relationship of tranexamic acid. Anesthesiology. 82 (1995), 383–392, 10.1097/00000542-199502000-00009.
13. Görlinger, K., Pérez-Ferrer, A., Dirkmann, D., et al. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean J Anesthesiol. 72 (2019), 297–322, 10.4097/kja.19169.
14. Dyke, C., Aronson, S., Dietrich, W., et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg. 147 (2014), 1458–1463.e1, 10.1016/j.jtcvs.2013.10.070.
15. Fiechtner, B.K., Nuttall, G.A., Johnson, M.E., et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg. 92 (2001), 1131–1136, 10.1097/00000539-200105000-00010.
16. Koster, A., Faraoni, D., Levy, J.H., Antifibrinolytic therapy for cardiac surgery: An update. Anesthesiology. 123 (2015), 21–214, 10.1097/ALN.0000000000000688.
17. Myles, P.S., Smith, J.A., Forbes, A., et al. Tranexamic acid in patients undergoing coronary-artery surgery [published correction appears in N Engl J Med. 2018;378:782]. N Engl J Med. 376 (2017), 136–148, 10.1056/NEJMoa1606424.
18. Longstaff, C., Measuring fibrinolysis: From research to routine diagnostic assays. J Thromb Haemost. 16 (2018), 652–662, 10.1111/jth.13957.
19. Levy, J.H., Koster, A., Quinones, Q.J., Milling, T.J., Key, N.S., Antifibrinolytic therapy and perioperative considerations. Anesthesiology. 128 (2018), 657–670, 10.1097/ALN.0000000000001997.
20. Faraoni, D., Rozen, L., Willems, A., et al. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease. Blood Coagul Fibrinolysis. 26 (2015), 290–297, 10.1097/MBC.0000000000000238.
21. Ng, W., Jerath, A., Wąsowicz, M., Tranexamic acid: A clinical review. Anaesthesiol Intensive Ther. 47 (2015), 339–350, 10.5603/AIT.a2015.0011.
22. Faraoni, D., Cacheux, C., van Aelbrouck, C., Ickx, B.E., Barvais, L., Levy, J.H., Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: A randomised, controlled study. Eur J Anaesthesiol. 31 (2014), 491–498, 10.1097/EJA.0000000000000051.
23. Ide, M., Bolliger, D., Taketomi, T., Tanaka, K.A., Lessons from the aprotinin saga: Current perspective on antifibrinolytic therapy in cardiac surgery. J Anesth. 24 (2010), 96–106, 10.1007/s00540-009-0866-9.
24. Shi, J., Zhou, C., Liu, S., et al. Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial. Am Heart J. 222 (2020), 147–156, 10.1016/j.ahj.2019.09.010.
25. Guo, J., Gao, X., Ma, Y., et al. Different dose regimes and administration methods of tranexamic acid in cardiac surgery: A meta-analysis of randomized trials. BMC Anesthesiol., 19, 2019, 129, 10.1186/s12871-019-0772-0.
26. Besser, M.W., Ortmann, E., Klein, A.A., Haemostatic management of cardiac surgical haemorrhage. Anaesthesia. 70:Suppl 1 (2015), 87–95, 10.1111/anae.12898.
27. Paparella, D., Brister, S.J., Buchanan, M.R., Coagulation disorders of cardiopulmonary bypass: A review. Intensive Care Med. 30 (2004), 1873–1881, 10.1007/s00134-004-2388-0.
28. Zaky, A., Thromboelastometry versus rotational thromboelastography in cardiac surgery. Semin Cardiothorac Vasc Anesth. 21 (2017), 206–211, 10.1177/1089253217697146.
29. Draxler, D.F., Yep, K., Hanafi, G., et al. Tranexamic acid modulates the immune response and reduces postsurgical infection rates. Blood Adv. 3 (2019), 1598–1609, 10.1182/bloodadvances.2019000092.
30. Mou, Q., Zhou, Q., Liu, S., Blood clot parameters: Prejudgment of fibrinolysis in thromboelastography. Clin Chim Acta. 479 (2018), 94–97, 10.1016/j.cca.2018.01.023.